Ischemic heart disease, factor predisposing to Barrett’s adenocarcinoma: A case control study

Table 5 Logistic regression analysis, in the whole study population, for known risk factors for esophageal adenocarcinoma development, various conditions co-existing with non-steroidal anti-inflammatory drugs use and various subgroups of non-steroidal anti-inflammatory drugs use

Variable	Odds ratio	CI of odds ratio	P
Age (per decade)	1.315	1.220-1.514	<0.001
Male gender	0.946	0.622-1.437	0.75
BE length (per 5 cm)	1.289	1.043-1.547	0.045
Length of HH (per 5 cm)	0.924	0.847-1.007	0.06
Duration of reflux (in decades)	1.848	1.686-2.060	<0.001
IHD	2.086	1.339-3.257	0.001
Daily aspirin use	0.623	0.346-1.111	0.65
Use of statins	0.576	0.356-0.918	0.02
Low socioeconomic status	1.411	0.844-2.351	0.43

IHD: Ischaemic heart disease; BE: Barrett esophagus.